As a global biotechnology company, MINAPHARM is providing intelligent biopharmaceutical solutions to world leaders in the industry.
Our wholly owned Berlin-based German subsidiary, ProBioGen AG, is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. ProBioGen AG has extensive expertise in cell line engineering, process development (upstream- and downstream processes) and GMP. Innovative scientific excellence, coupled with a strong intellectual property base, allows ProBioGen AG to cover the entire drug development value chain, including regulatory support for IND-filing. All services and technologies are embedded within a total quality management system, to assure compliance with international ISO and GMP standards (EMA/FDA). At the Cairo-based Rhein-Minapharm, a group of young talented Egyptian scientists represent the first-research community in the Middle East region to develop novel processes for the production of genetically engineered drugs.